BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He D, Guo Z, Pu JL, Zheng DF, Wei XF, Liu R, Tang CY, Wu ZJ. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo. Int Immunopharmacol 2016;35:201-9. [PMID: 27064547 DOI: 10.1016/j.intimp.2016.03.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Chang C, Zhao Y, Song G, She K. Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats. Journal of Neuroimmunology 2018;315:9-14. [DOI: 10.1016/j.jneuroim.2017.11.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
2 Lu WJ, Lin KH, Tseng MF, Yuan KC, Huang HC, Sheu JR, Chen RJ. New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury. J Cell Mol Med 2019;23:1723-34. [PMID: 30548082 DOI: 10.1111/jcmm.14070] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Xu LQ, Xie YL, Gui SH, Zhang X, Mo ZZ, Sun CY, Li CL, Luo DD, Zhang ZB, Su ZR, Xie JH. Polydatin attenuates d-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice. Food Funct. 2016;7:4545-4555. [PMID: 27714005 DOI: 10.1039/c6fo01057a] [Cited by in Crossref: 66] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
4 He D, Ma Z, Fang C, Ding J, Yang W, Chen P, Huang L, Wang C, Yu Y, Yang L, Li Y, Zhou Z. Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer. Cancer Lett 2019;454:53-65. [PMID: 30981757 DOI: 10.1016/j.canlet.2019.04.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Huang Z, Mou T, Luo Y, Pu X, Pu J, Wan L, Gong J, Yang H, Liu Y, Li Z, Shen A, Wu Z. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death Dis 2020;11:455. [PMID: 32532961 DOI: 10.1038/s41419-020-2648-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
6 Cheng MX, Huang P, He Q, Chen Y, Li JZ. Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats. J Invest Surg 2019;32:298-303. [PMID: 29286833 DOI: 10.1080/08941939.2017.1412543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Le K, Chibaatar Daliv E, Wu S, Qian F, Ali AI, Yu D, Guo Y. SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: A possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury. Int Immunopharmacol 2019;75:105779. [PMID: 31362164 DOI: 10.1016/j.intimp.2019.105779] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
8 Luo W, Li L, Xu W, Zhang J, Xu J. Toxic Effects of Docosahexaenoic Acid Treatment in the Rat Liver BRL-3A Cell. Toxics 2021;9:112. [PMID: 34065295 DOI: 10.3390/toxics9050112] [Reference Citation Analysis]
9 Narayanankutty A. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases. Curr Drug Targets 2019;20:1068-80. [PMID: 30806312 DOI: 10.2174/1389450120666190222181506] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
10 Dai J, Chen Q, Huang W, Shi K, Zhang Y, Li T, Mou T, Huang Z, Wu Z. Liver kinase B1 attenuates liver ischemia/reperfusion injury via inhibiting the NLRP3 inflammasome. Acta Biochim Biophys Sin (Shanghai) 2021;53:601-11. [PMID: 33783473 DOI: 10.1093/abbs/gmab030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang H, Gu J, Hou X, Chen J, Yang N, Liu Y, Wang G, Du M, Qiu H, Luo Y, Jiang Z, Feng L. Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4/NF-κB/IQGAP2 signaling pathway. Biomed Pharmacother 2017;85:531-40. [PMID: 27903427 DOI: 10.1016/j.biopha.2016.11.061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
12 Wang G, Hu Z, Fu Q, Song X, Cui Q, Jia R, Zou Y, He C, Li L, Yin Z. Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade. Sci Rep 2017;7:45006. [PMID: 28322346 DOI: 10.1038/srep45006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
13 Jia YN, Lu HP, Peng YL, Zhang BS, Gong XB, Su J, Zhou Y, Pan MH, Xu L. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Int Immunopharmacol 2018;56:105-12. [PMID: 29414639 DOI: 10.1016/j.intimp.2018.01.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
14 Kamel EO, Hassanein EHM, Ahmed MA, Ali FEM. Perindopril Ameliorates Hepatic Ischemia Reperfusion Injury Via Regulation of NF‐κB‐p65/TLR‐4, JAK1/STAT‐3, Nrf‐2, and PI3K/Akt/mTOR Signaling Pathways. Anat Rec 2020;303:1935-49. [DOI: 10.1002/ar.24292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Bilen A, Mercantepe F, Tümkaya L, Yilmaz A, Batcik Ş. The hepatoprotective potential of resveratrol in an experimental model of ruptured abdominal aortic aneurysm via oxidative stress and apoptosis. J Biochem Mol Toxicol 2021;35:e22836. [PMID: 34075649 DOI: 10.1002/jbt.22836] [Reference Citation Analysis]
16 Zhang Y, Zhang H, Zhang Z, Li S, Jiang W, Li X, Lv J. LncRNA MALAT1 cessation antagonizes hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and inflammation via the HMGB1-TLR4 axis. Molecular Immunology 2019;112:22-9. [DOI: 10.1016/j.molimm.2019.04.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
17 Deng Z, Xu XY, Yunita F, Zhou Q, Wu YR, Hu YX, Wang ZQ, Tian XF. Synergistic anti-liver cancer effects of curcumin and total ginsenosides. World J Gastrointest Oncol 2020; 12(10): 1091-1103 [PMID: 33133379 DOI: 10.4251/wjgo.v12.i10.1091] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Huang Z, Zheng D, Pu J, Dai J, Zhang Y, Zhang W, Wu Z. MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway. Biosci Biotechnol Biochem 2019;83:829-35. [PMID: 30686117 DOI: 10.1080/09168451.2019.1569495] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
19 Lu JM, Jin GN, Lu YN, Zhao XD, Lan HW, Mu SR, Shen XY, Xu GH, Jin CH, Ma J, Jin X, Xu X, Piao LX. Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway. Eur J Pharmacol 2021;910:174497. [PMID: 34508751 DOI: 10.1016/j.ejphar.2021.174497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Motiño O, Francés DE, Casanova N, Fuertes-Agudo M, Cucarella C, Flores JM, Vallejo-Cremades MT, Olmedilla L, Pérez Peña J, Bañares R, Boscá L, Casado M, Martín-Sanz P. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice. Hepatology 2019;70:650-65. [PMID: 30155948 DOI: 10.1002/hep.30241] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
21 Hu C, Li L. Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion. J Cell Mol Med 2017;21:1719-31. [PMID: 28301072 DOI: 10.1111/jcmm.13129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
22 Du Y, Qian B, Gao L, Tan P, Chen H, Wang A, Zheng T, Pu S, Xia X, Fu W. Aloin Preconditioning Attenuates Hepatic Ischemia/Reperfusion Injury via Inhibiting TLR4/MyD88/NF-κB Signal Pathway In Vivo and In Vitro. Oxid Med Cell Longev 2019;2019:3765898. [PMID: 31827674 DOI: 10.1155/2019/3765898] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
23 Sherif IO, Al-Shaalan NH. Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway. Oxid Med Cell Longev 2018;2018:3509091. [PMID: 30405876 DOI: 10.1155/2018/3509091] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
24 Cheng O, Tian X, Luo Y, Mai S, Yang Y, Kuang S, Chen Q, Ma J, Chen B, Li R, Yang L, Li H, Hu C, Zhang J, Chen Z, Li Y, Xia H, Xu Y, Yang J. Liver X receptors agonist promotes differentiation of rat bone marrow derived mesenchymal stem cells into dopaminergic neuron-like cells. Oncotarget 2018;9:576-90. [PMID: 29416637 DOI: 10.18632/oncotarget.23076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
25 Luo Y, Zheng D, Mou T, Pu J, Huang Z, Chen W, Zhang Y, Wu Z. CMPK2 accelerates liver ischemia/reperfusion injury via the NLRP3 signaling pathway. Exp Ther Med 2021;22:1358. [PMID: 34659504 DOI: 10.3892/etm.2021.10793] [Reference Citation Analysis]
26 Yang L, Jiang L, Jiang D, Liu B, Jin S. The protective effects of salvianolic acid A against hepatic ischemia-reperfusion injury via inhibiting expression of toll-like receptor 4 in rats. Arch Med Sci 2019;15:1599-607. [PMID: 31749890 DOI: 10.5114/aoms.2019.87412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wang L, Li N, Lin D, Zang Y. Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-κB pathway. Oncotarget 2017;8:65414-20. [PMID: 29029441 DOI: 10.18632/oncotarget.18676] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
28 Mou T, Luo Y, Huang Z, Zheng D, Pu X, Shen A, Pu J, Li T, Dai J, Chen W, Wu Z. Inhibition of microRNA-128-3p alleviates liver ischaemia-reperfusion injury in mice through repressing the Rnd3/NF-κB axis. Innate Immun 2020;26:528-36. [PMID: 32486927 DOI: 10.1177/1753425920928449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
29 Cherif-Sayadi A, Hadj Ayed-Tka K, Zaouali MA, Bejaoui M, Hadj-Abdallah N, Bouhlel A, Ben Abdennebi H. Nitrite enhances liver graft protection against cold ischemia reperfusion injury through a NOS independent pathway. Libyan J Med 2017;12:1308780. [PMID: 28357909 DOI: 10.1080/19932820.2017.1308780] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Aktaş HS, Ozel Y, Ahmad S, Pençe HH, Ayaz-adakul B, Kudas I, Tetik S, Şekerler T, Canbey-göret C, Kabasakal L, Elcioglu HK. Protective effects of resveratrol on hepatic ischemia reperfusion injury in streptozotocin-induced diabetic rats. Mol Cell Biochem 2019;460:217-24. [DOI: 10.1007/s11010-019-03582-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]